Elisabeth Lea Vikse
overingeniør, MSc Molecular Biology
Kontakt
Send e-post {model.translations.sendEmailTo} Elisabeth.Vikse@fhi.no
Avdeling
Prosjekter og publikasjoner
- Even Fossum, Elisabeth Lea Vikse, Anna Hayman Robertson, Asia-Sophia Fumika Michaela Wolf, Andreas Rohringer, Lill Trogstad, Siri Mjaaland, Olav Hungnes, Karoline Bragstad, (2025). Low Levels of Neutralizing Antibodies Against SARS-CoV-2 KP.3.1.1 and XEC in Serum From Seniors in May 2024. Influenza and Other Respiratory Viruses doi: 10.1111/irv.70102
- Gro Tunheim, Even Fossum, Anna Hayman Robertson, Gunnar Øyvind Isaksson Rø, Adity Chopra, John T. Vaage, Elisabeth Lea Vikse, Anne-Marte Bakken Kran, Per Minor Magnus, Lill Trogstad, Siri Mjaaland, Olav Hungnes, Fridtjof Lund-Johansen, (2024). Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults. BMC Infectious Diseases s. 1-20. doi: 10.1186/s12879-024-09670-w
- Sopisa Benjakul, Aina Karen Anthi, Heidi Anette Kolderup, Marina Vaysburd, Heidrun Elisabeth Lode, D Mallery, Even Fossum, Elisabeth Lea Vikse, Anna Albecka, Aleksandr Ianevski, Denis Kaynov, Karine Flem Karlsen, Siri Aastedatter Sakya, Mari Nyquist-Andersen, torleif gjølberg, Morten Carsten Moe, Magnar Bjørås, Inger Sandlie, Leo C. James, Jan Terje Andersen, (2023). A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery. PNAS Nexus s. 1-15. doi: 10.1093/pnasnexus/pgad403
- Elisabeth Lea Vikse, Even Fossum, Magnhild Sekse Erdal, Olav Hungnes, Karoline Bragstad, (2023). Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022. Influenza and Other Respiratory Viruses s. 1-6. doi: 10.1111/irv.13144
- Gunnveig Grødeland, Agnete Fredriksen, Geir Åge Løset, Elisabeth Lea Vikse, Lars Fugger, Bjarne Bogen, (2016). Antigen targeting to human HLA Class II molecules increases efficacy of DNA vaccination. Journal of Immunology s. 3575-3585. doi: 10.4049/jimmunol.1600893
- Even Fossum, Gunnveig Grødeland, Dorothea Terhorst, Anders Tveita, Elisabeth Lea Vikse, Siri Mjaaland, Sandrine Henri, Bernard Malissen, Bjarne Bogen, (2015). Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. European Journal of Immunology s. 624-635. doi: 10.1002/eji.201445080
- Aurelia Lewis, Marte Rusten, Erling Andre Høivik, Elisabeth Lea Vikse, Magnus L. Hansson, Annika E. Wallberg, Marit Bakke, (2008). Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. Molecular Endocrinology s. 91-104. doi: 10.1210/me.2006-0478